Age, biological sex, and apolipoprotein E (APOE) genotype are associated with Alzheimer’s disease (AD) risk. Although the APOE3 allele confers neutral risk, APOE4 is strongly linked to increased AD risk and severity, especially in post-menopausal women. Estrogen loss at menopause may contribute to women’s elevated AD risk, and is further associated with symptoms such as anxiety and hot flashes. Although effective against these symptoms and risks, estrogen therapies also promote risk of health concerns such as breast cancer by activating estrogen receptor ⍺. However, estrogen receptor β (ERβ) activation enhances memory and reduces hot flashes preclinically without harmful side effects. Therefore, ERβ agonists might be useful therapeutics for...
Although animal and clinical studies suggest estrogen therapy can benefit cognitive function in agin...
The menopausal loss of circulating hormones, including estrogens, is associated with negative sympto...
: Background: Many studies have shown that estrogen replacement therapy may improve cognitive functi...
Background Women are at greater risk of Alzheimer’s Disease (AD) than men, and symptoms associated w...
Background Women are at greater risk of Alzheimer’s Disease (AD) than men, and symptoms associated w...
Background Women are at greater risk of Alzheimer’s Disease (AD) than men, and symptoms associated w...
Alzheimer’s disease (AD) causes severe memory loss and other cognitive difficulties. Relative to men...
The APOE4 genotype is the leading genetic risk factor for Alzheimer’s disease (AD), and women APOE4 ...
Millions of women experience menopausal symptoms, such as hot flashes, anxiety, depression, and deme...
Millions of women experience menopausal symptoms, such as hot flashes, anxiety, depression, and deme...
Alzheimer's disease (AD) disproportionally affects women and men. The female susceptibility for AD h...
Alzheimer's disease (AD) disproportionally affects women and men. The female susceptibility for AD h...
# The Author(s) 2014. This article is published with open access at Springerlink.com Abstract Estrog...
Decreases of the sex steroids, testosterone and estrogen, are associated with increased risk of Alzh...
Alzheimer’s disease (AD) is the most common form of dementia, yet its cause remains a mystery and no...
Although animal and clinical studies suggest estrogen therapy can benefit cognitive function in agin...
The menopausal loss of circulating hormones, including estrogens, is associated with negative sympto...
: Background: Many studies have shown that estrogen replacement therapy may improve cognitive functi...
Background Women are at greater risk of Alzheimer’s Disease (AD) than men, and symptoms associated w...
Background Women are at greater risk of Alzheimer’s Disease (AD) than men, and symptoms associated w...
Background Women are at greater risk of Alzheimer’s Disease (AD) than men, and symptoms associated w...
Alzheimer’s disease (AD) causes severe memory loss and other cognitive difficulties. Relative to men...
The APOE4 genotype is the leading genetic risk factor for Alzheimer’s disease (AD), and women APOE4 ...
Millions of women experience menopausal symptoms, such as hot flashes, anxiety, depression, and deme...
Millions of women experience menopausal symptoms, such as hot flashes, anxiety, depression, and deme...
Alzheimer's disease (AD) disproportionally affects women and men. The female susceptibility for AD h...
Alzheimer's disease (AD) disproportionally affects women and men. The female susceptibility for AD h...
# The Author(s) 2014. This article is published with open access at Springerlink.com Abstract Estrog...
Decreases of the sex steroids, testosterone and estrogen, are associated with increased risk of Alzh...
Alzheimer’s disease (AD) is the most common form of dementia, yet its cause remains a mystery and no...
Although animal and clinical studies suggest estrogen therapy can benefit cognitive function in agin...
The menopausal loss of circulating hormones, including estrogens, is associated with negative sympto...
: Background: Many studies have shown that estrogen replacement therapy may improve cognitive functi...